Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
(NYSE: VAR) Zoetis Inc (NYSE: ZTS) Down In The Dumps (Biotech stocks hitting 52-week lows on April 1) Cyclacel Pharmaceuticals Inc (NASDAQ: CYC)(reacted to a Phase 1 data for its DNA damage response program with an oral, sequential regimen of sapacitabine and seliciclib as a treatment in patients with BRCA mutant metastatic breast cancer) Hoth Therapeutics Inc (NASDAQ: HOT) RA Medical Systems Inc (NYSE: RMED) Stock In FocusDare Bioscience Shares Regain Compliance With Nasdaq Listing Standards Dare Bioscience Inc (NASDAQ: DARE) said it has regained compliance with the minimum bid price requirement of the Nasdaq by virtue of its shares trading at $1 per share or greater for 10 consecutive business days
Manufactured at a verified purity of 99% or higher, it is intended solely for professional laboratory testing and research environments
doi: 10.1016/s0925-4773(00)00439-1 98 FisherFMEstallJLAdamsACAntonellisPJBinaHAFlierJSet al
Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report
US$ 23.79
US$ 29.31
/product/19/3469114/1.jpg?9363)
US$ 20.27
US$ 27.05
US$ 22.63
US$ 23.30
US$ 23.91
US$ 25.70
